<SEC-DOCUMENT>0000950142-22-001799-index.html : 20220601
<SEC-HEADER>0000950142-22-001799.hdr.sgml : 20220601
<ACCEPTANCE-DATETIME>20220601160132
ACCESSION NUMBER:		0000950142-22-001799
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220601
DATE AS OF CHANGE:		20220601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NRX Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001719406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				822844431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-257438
		FILM NUMBER:		22987282

	BUSINESS ADDRESS:	
		STREET 1:		1201 N. MARKET STREET
		STREET 2:		SUITE 111
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801
		BUSINESS PHONE:		484-254-6134

	MAIL ADDRESS:	
		STREET 1:		1201 N. MARKET STREET
		STREET 2:		SUITE 111
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Rock Partners Acquisition Corp.
		DATE OF NAME CHANGE:	20171012
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>eh220257569_424b3-438.htm
<DESCRIPTION>FORM 424B3
<TEXT>
Document 1 - file: eh220257569_424b3-438.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>company_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: company_logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>